Zacks Research Issues Optimistic Forecast for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Equities research analysts at Zacks Research lifted their Q1 2027 earnings per share estimates for shares of Phibro Animal Health in a report issued on Tuesday, January 7th. Zacks Research analyst R. Department now forecasts that the company will post earnings of $0.49 per share for the quarter, up from their previous estimate of $0.47. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.62 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2027 earnings at $0.53 EPS.

Other equities research analysts have also recently issued research reports about the company. Morgan Stanley boosted their target price on Phibro Animal Health from $20.00 to $25.00 and gave the company an “equal weight” rating in a research note on Tuesday, December 17th. StockNews.com upgraded Phibro Animal Health from a “buy” rating to a “strong-buy” rating in a research note on Saturday, January 4th. Finally, Barclays boosted their target price on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $20.50.

Phibro Animal Health Price Performance

Shares of PAHC opened at $21.48 on Friday. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23. The stock has a 50 day simple moving average of $22.81 and a 200 day simple moving average of $21.06. Phibro Animal Health has a 52-week low of $10.03 and a 52-week high of $25.98. The firm has a market capitalization of $870.00 million, a PE ratio of 49.95, a P/E/G ratio of 0.58 and a beta of 0.53.

Phibro Animal Health Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.23%. The ex-dividend date of this dividend was Wednesday, November 27th. Phibro Animal Health’s dividend payout ratio is currently 111.63%.

Institutional Investors Weigh In On Phibro Animal Health

A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Brandes Investment Partners LP raised its stake in Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock valued at $40,521,000 after acquiring an additional 29,071 shares during the period. Dimensional Fund Advisors LP raised its stake in Phibro Animal Health by 5.7% in the 2nd quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after acquiring an additional 42,086 shares during the period. Dana Investment Advisors Inc. raised its stake in Phibro Animal Health by 17.2% in the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock valued at $8,619,000 after acquiring an additional 75,546 shares during the period. Geode Capital Management LLC raised its stake in Phibro Animal Health by 5.7% in the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock valued at $11,430,000 after acquiring an additional 27,201 shares during the period. Finally, American Century Companies Inc. raised its stake in Phibro Animal Health by 119.6% in the 2nd quarter. American Century Companies Inc. now owns 347,191 shares of the company’s stock valued at $5,822,000 after acquiring an additional 189,068 shares during the period. Institutional investors own 99.34% of the company’s stock.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.